Radiation therapy of sinonasal natural killer/T-cell lymphoma

被引:2
|
作者
Riet, F. -G. [1 ]
Canova, C. -H. [1 ]
Gabarre, J. [2 ]
Ben Hassine, S. [1 ]
Kom, L. Kamsu [1 ]
Mazeron, J. -J. [1 ]
Feuvret, L. [1 ]
机构
[1] Grp Hosp Pitie Salpetriere, AP HP, Serv Oncol Radiotheapie, F-75651 Paris 13, France
[2] Grp Hosp Pitie Salpetriere, AP HP, Serv Hepatol, F-75651 Paris 13, France
来源
CANCER RADIOTHERAPIE | 2014年 / 18卷 / 02期
关键词
Natural killer (NK)/T-cell lymphoma; Nasal cavity; Radiation therapy; Chemotherapy; Combined chemoradiation; INTENSITY-MODULATED RADIOTHERAPY; WORLD-HEALTH-ORGANIZATION; INTERNATIONAL PROGNOSTIC INDEX; STAGE NASOPHARYNGEAL CARCINOMA; INVOLVED-FIELD RADIATION; ANGIOCENTRIC T-CELL; NASAL-TYPE; (NK)/T-CELL LYMPHOMA; SMILE CHEMOTHERAPY; SINGLE-CENTER;
D O I
10.1016/j.canrad.2013.11.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Natural killer (NK)/T-cell lymphoma are part of lymphoproliferative diseases, they are rare in Europe and the United States but relatively common in Asia and South America. Natural killer (NK)/T-cell lymphoma present clinically as destructive lesions of the upper aerodigestive tract with perforation of deep structures of the face, destruction of the palate or an invasion of orbits. Treatment modalities of these lymphomas are still discussed because of the lack of available studies and the rarity of this disease. Radiotherapy provides a rapid control of the disease and is positioned as a major treatment of localized stages of NK/T-cell lymphoma of the nasal cavity. We therefore studied the different forms of radiation therapy in the early stages of nasal NK/T-cell lymphoma. (C) 2013 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:147 / 153
页数:7
相关论文
共 50 条
  • [21] CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma?
    Kim, WS
    Song, SY
    Ahn, YC
    Ko, YH
    Baek, CH
    Kim, DY
    Yoon, SS
    Lee, HG
    Kang, WK
    Lee, HJ
    Park, CH
    Park, K
    ANNALS OF ONCOLOGY, 2001, 12 (03) : 349 - 352
  • [22] Treatment outcomes of T and natural-killer/T-cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy
    Tay, Tricia
    Somasundaram, Nagavalli
    Lim, Cindy
    Khoo, Lay Poh
    Goh, Allan Zhi Kai
    Lee, Yuh Shan
    Liu, Xin
    Tao, Miriam
    Quek, Richard
    Farid, Mohamad
    Poon, Eileen
    Chan, Jason Y. S.
    Chang, Esther W. Y.
    Yang, Valerie S. W.
    Goh, Yeow Tee
    Tan, Daryl
    Diong, Colin
    Grigoropoulos, Nicholas F.
    Nagarajan, Chandramouli
    Poon, Michelle
    Mel, Sanjay
    Jeyasekharan, Anand
    Chan, Esther H. L.
    Lee, Joanne
    Chee, Yen Lin
    Lim, Soon Thye
    Tang, Tiffany
    CANCER REPORTS, 2022, 5 (09)
  • [23] Sinonasal NK/T-cell lymphoma
    Hmidi, M.
    Kettani, M.
    Elboukhari, A.
    Touiheme, N.
    Messary, A.
    EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2013, 130 (03) : 145 - 147
  • [24] A prospective study of chemoradiotherapy for early stage extranodal natural killer (NK)/T-cell lymphoma
    Zhou, Fei
    Xue, Hongwei
    Zhao, Yanwei
    Liu, Xiaoran
    Dong, Qing
    Yu, Hongsheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (07): : 14397 - 14403
  • [25] SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group
    Kwong, Yok-Lam
    Kim, Won Seog
    Lim, Soon Thye
    Kim, Seok Jin
    Tang, Tiffany
    Tse, Eric
    Leung, Anskar Y. H.
    Chim, Chor-Sang
    BLOOD, 2012, 120 (15) : 2973 - 2980
  • [26] Novel targets for natural killer/T-cell lymphoma immunotherapy
    Kumai, Takumi
    Kobayashi, Hiroya
    Harabuchi, Yasuaki
    IMMUNOTHERAPY, 2016, 8 (01) : 45 - 55
  • [27] Extranodal natural killer/T-cell lymphoma with tonsil involvement: a case report
    Xiao, Yang
    Zhang, Xing
    Gao, Yingqin
    Lin, Ken
    Chi, Wenyue
    Zhou, Kaijian
    Ma, Jing
    Zhang, Tiesong
    BMC ORAL HEALTH, 2024, 24 (01):
  • [28] The pretreatment albumin to globulin ratio predicts survival in patients with natural killer/T-cell lymphoma
    Bi, Xi-wen
    Wang, Liang
    Zhang, Wen-wen
    Yan, Shu-mei
    Sun, Peng
    Xia, Yi
    Li, Zhi-ming
    Jiang, Wen-qi
    PEERJ, 2016, 4
  • [29] Primary cutaneous extranodal natural killer/T-cell lymphoma
    Basavaraj, Vijaya
    Kumararadhya, Rashmi
    Sunila
    Vimala, Manjunath
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2014, 80 (06) : 562 - U164
  • [30] The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation
    de Mel, Sanjay
    Soon, Gwyneth Shook-Ting
    Mok, Yingting
    Chung, Tae-Hoon
    Jeyasekharan, Anand D.
    Chng, Wee-Joo
    Ng, Siok-Bian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (07)